Literature DB >> 34489305

SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases.

Saskia Lawson-Tovey1,2, Kimme L Hyrich2,3, Laure Gossec4,5, Anja Strangfeld6, Loreto Carmona7, Bernd Raffeiner8, Gözde Kübra Yardımcı9, Ludovic Trefond10, Nicolas Roux11, Ana Rodrigues12,13, Charalampos Papagoras14, Elsa F Mateus15,16, Xavier Mariette17, Pedro M Machado18,19,20.   

Abstract

Entities:  

Keywords:  COVID-19; epidemiology; vaccination

Mesh：

Substances：

Year:  2021        PMID： 34489305     DOI： 10.1136/annrheumdis-2021-221217

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Evaluation of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Levels in Coronavirus Disease Breakthrough Infection During Immunosuppressive Therapy in a Patient with Connective Tissue Disease-Related Interstitial Lung Disease.

Authors:  Takuma Tsuzuki Wada; Kazuhiro Yokota; Sakon Sakai; Machika Soma; Hiroshi Kajiyama; Norihito Tarumoto; Shigefumi Maesaki; Takuya Maeda; Makoto Nagata; Toshihide Mimura
Journal:  Mod Rheumatol Case Rep       Date:  2022-06-22

2.  Immunosuppression and SARS-CoV-2 breakthrough infections.

Authors:  Alfred H J Kim; Jeffrey A Sparks
Journal:  Lancet Rheumatol       Date:  2022-04-29

3.  Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination.

Authors:  Davide Firinu; Andrea Perra; Marcello Campagna; Roberto Littera; Giuseppe Fenu; Federico Meloni; Selene Cipri; Francesca Sedda; Maria Conti; Michela Miglianti; Giulia Costanzo; Marta Secci; Gianmario Usai; Mauro Giovanni Carta; Riccardo Cappai; Germano Orrù; Stefano Del Giacco; Ferdinando Coghe; Luchino Chessa
Journal:  Clin Exp Med       Date:  2021-11-05       Impact factor: 5.057

4.  SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.

Authors:  Jean Liew; Milena Gianfrancesco; Carly Harrison; Zara Izadi; Stephanie Rush; Saskia Lawson-Tovey; Lindsay Jacobsohn; Clairissa Ja; Kimme L Hyrich; Laure Gossec; Anja Strangfeld; Loreto Carmona; Martin Schäfer; Elsa Frãzao-Mateus; Inita Bulina; Frances Stafford; Abdurrahman Tufan; Christine Graver; Gözde Kübra Yardımcı; Julija Zepa; Samar Al Emadi; Claire Cook; Fatemah Abutiban; Dfiza Dey; Genevieve Katigbak; Lauren Kaufman; Emily Kowalski; Marco Ulises Martínez-Martínez; Naomi J Patel; Greta Reyes-Cordero; Evelyn Salido; Ellison Smith; David Snow; Jeffrey Sparks; Leanna Wise; Suleman Bhana; Monique Gore-Massy; Rebecca Grainger; Jonathan Hausmann; Emily Sirotich; Paul Sufka; Zachary Wallace; Pedro M Machado; Philip C Robinson; Jinoos Yazdany
Journal:  RMD Open       Date:  2022-04

Review 5.  COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.

Authors:  Rebecca Grainger; Alfred H J Kim; Richard Conway; Jinoos Yazdany; Philip C Robinson
Journal:  Nat Rev Rheumatol       Date:  2022-02-25       Impact factor: 32.286

6.  Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis.

Authors:  Maurizio Benucci; Arianna Damiani; Francesca Li Gobbi; Barbara Lari; Valentina Grossi; Maria Infantino; Mariangela Manfredi
Journal:  Immunol Res       Date:  2022-05-11       Impact factor: 4.505

7.  SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.

Authors:  Saskia Lawson-Tovey; Pedro M Machado; Anja Strangfeld; Elsa Mateus; Laure Gossec; Loreto Carmona; Bernd Raffeiner; Inita Bulina; Daniel Clemente; Julija Zepa; Ana M Rodrigues; Xavier Mariette; Kimme L Hyrich
Journal:  RMD Open       Date:  2022-07

8.  Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure.

Authors:  Ana-Luisa Stefanski; Hector Rincon-Arevalo; Eva Schrezenmeier; Kirsten Karberg; Franziska Szelinski; Jacob Ritter; Yidan Chen; Christian Meisel; Bernd Jahrsdörfer; Carolin Ludwig; Hubert Schrezenmeier; Andreia C Lino; Thomas Dörner
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

9.  Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy.

Authors:  Kathleen Mm Vanni; Naomi J Patel; Michael DiIorio; Emily Kowalski; Grace Qian; Claire E Cook; Susan Y Ritter; Zachary S Wallace; Jeffrey A Sparks
Journal:  RMD Open       Date:  2022-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.